Trial Profile
A Phase 4, Open-Label, Single-Group Immunogenicity and Safety Study of Re-exposure to RECOTHROM (rThrombin) in Surgical Hemostasis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 May 2014
Price :
$35
*
At a glance
- Drugs Thrombin alfa (Primary)
- Indications Surgical blood loss
- Focus Pharmacodynamics
- Sponsors ZymoGenetics
- 28 May 2014 New trial record